Latest News

New drugs offer hope for migraine prevention

Two new studies may offer hope for people with migraines. Both studies involve drugs that are aimed at preventing migraine attacks from occurring, rather than stopping the attacks once they have started. These studies are the first to test monoclonal antibodies for the prevention of migraine, and both are directed against a relatively new target in migraine prevention, the calcitonin gene-related peptide, or CGRP. CGRP has been thought to be important in migraine, but never have drugs been developed to specifically target the protein.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Mother's diet influences weight-control neurocircuits in offspring

  • Rate of opioid misuse is around 25 percent, addiction rate 10 percent, reports study

  • Prototype 'nanoneedles' generate new blood vessels in mice, paving way for new regenerative medicine

  • Component of red grapes, wine could help ease depression

  • Crowdsourced tool for depression

  • Mechanisms that link compulsive binge eating with hypertension identified

  • New link between neurodegenerative diseases, abnormal immune responses found

  • Super sensitive measurement of magnetic fields

  • Family income, parental education related to brain structure in children, adolescents

  • 'Lightning bolts' in brain show learning in action

  •